Navigation Links
JAMA publication features study on depression and head and neck cancer
Date:5/19/2008

A University of Nebraska Medical Center-led pilot study that showed antidepressants can significantly reduce the risk of depression for head and neck cancer patients is the focus of an article published today in the Archives of Otolaryngolgy -- one of the publications produced by the Journal of American Medical Association (JAMA).

The study, which was led by UNMCs William Lydiatt, M.D., and Bill Burke, M.D., showed that only 15 percent of head and neck cancer patients who took antidepressants as part of their treatment experienced depression. Thats a hopeful sign considering that 50 percent of the patients in the study group who didnt take antidepressants experienced depression.

These statistics offer hope for head and neck cancer patients, said Dr. Lydiatt, division director of head and neck surgical oncology in the department of otolaryngology-head and neck surgery, because depression is the number one reason head and neck cancer patients dont complete treatment.

This is a potentially important study and result because it shows for the first time that depression can be prevented for those with head and neck cancer, Dr. Lydiatt said.

The National Institutes of Health seem to agree with Dr. Lydiatts take on the studys importance. After seeing the results of the pilot study, the NIH granted the UNMC team $1.6 million to expand the study.

While head and neck cancer patients represent a fairly small percentage of those with cancer, they do account for an extraordinarily high percentage of cancer-patient suicides, said Dr. Burke, professor of psychiatry.

For example, he said, patients with tongue and larynx cancer compose only 2 percent of all cancer cases but they account for about 20 percent of suicides committed by cancer patients.

A variety of reasons exist for the increased rates of depression in head and neck cancer patients, Dr. Burke said, including arduous treatment regimens; surgery and complications that interfere with eating and talking; and the psychological affects of having visible wounds left by the cancer.

Our study shows that we may be able to get out in front of depression in head and neck cancer patients and improve their chances of completing the needed treatment, Dr. Burke said.

The findings from the study also may have implications in terms of helping those with other forms of cancer avoid depression, Dr. Lydiatt said.

Ken Cowan, M.D., Ph.D., director of the UNMC Eppley Cancer Center, said the publication in the JAMA journal and the NIH grant are indicators that the work being done by Drs. Burke and Lydiatt has major implications in the treatment of head and neck cancer.

This study brings an immense amount of promise in terms of improving treatment for those with head and neck cancer, Dr. Cowan said.

Countless lives could be positively affected by the work being done by these scientists.

Steven Wengel, M.D., professor and chairman of the UNMC Department of Psychiatry, said he was excited to see the UNMC teams work recognized.

Drs. Lydiatt and Burke and their team are doing very important and exciting work, Dr. Wengel said. They have shown that effective collaboration across disciplines has the potential to save and improve many lives.


'/>"/>

Contact: Tom O'Connor
toconnor@unmc.edu
402-559-4690
University of Nebraska Medical Center
Source:Eurekalert

Related medicine news :

1. Open access to health research publications
2. Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel
3. Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
4. Scientific Publications Strategy & Delivery Shifts from Marketing to Medical
5. Telemedicine publication expands coverage
6. GSA confers 2007 Richard Kalish Innovative Publication Award to USCs Mather
7. Fry Construction Is Featured in Key Industry Publication
8. CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation
9. Nature publication on pain research
10. Bojan M. Kuure Recognized by Strathmores Whos Who Worldwide Publication
11. Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Each February the nation ... (officially African American History Month ). This month-long celebration encourages ... diverse race of people, but also the opportunity to examine the trends of ...
(Date:2/21/2017)... ... 2017 , ... One of the most prevalent health conditions ... and financial consequences of inaction. On March 3, World Hearing Day, the American ... about their hearing. , Effective treatment in the form of hearing aids and ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... Along with ... healthy lifestyle and make small changes that can lead to a lifetime of heart ... possibility of a cardiac emergency. , The Athletic Trainers’ Society of New ...
(Date:2/20/2017)... ... 2017 , ... Nancy Johnston Toll marks her debut in the ... the Bump in the Road ” (published by Xlibris). Inspired from her personal experiences, ... the ups and downs experienced by anyone going through cancer treatment and how one ...
(Date:2/20/2017)... ... 2017 , ... Scrubbing in for his first esophageal cancer case in the ... excitement of the surgeon training him. , “He was giddy and almost couldn’t contain ... anyone, but I would do it for free,’” Dr. Pezzi recalled. “He genuinely was ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... and Markets has announced the addition of the "Liver Cirrhosis Drugs ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... the following questions: What are the key drugs ... in the Global Liver Cirrhosis market? What are the ...
(Date:2/21/2017)... 21, 2017 Research and Markets has announced the ... report to their offering. ... The latest research Anthrax Drugs Price Analysis and Strategies - 2016, ... The research answers the following questions: What ... are they positioned in the Global Anthrax market? What ...
(Date:2/20/2017)... 20, 2017 Provides understanding and access ... into by the worlds leading healthcare companies. ... Description The Global Anemia Partnering Terms and Agreements ... partnering deals and agreements entered into by the ... in partnering deals - Top deals by ...
Breaking Medicine Technology: